Domů › Srdeční selhání › Missouri › St. Louis
Klinické studie Srdeční selhání v St. Louis, MO
26 studií pro Srdeční selhání hledá účastníky v lokalitách v St. Louis a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Probíhá náborFáze 3
- St. Louis Heart and Vascular, P.C., St Louis
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Probíhá náborFáze 3
- St. Louis Heart and Vascular, P.C., St Louis
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
Probíhá náborFáze 2
- Washington University School of Medicine, St Louis
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
Probíhá náborFáze 3
- Research Site, Bridgeton · Vzdálenost 15 mi
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
Probíhá náborFáze 3
- Washington University Center for Advanced Medicine, St Louis
A Study of LY3971297 in Participants With Heart Failure
Probíhá náborFáze 1
- Washington University, St Louis
Alleviant ALLAY-HFrEF Study
Probíhá nábor
- Washington University - St Louis, St Louis
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Probíhá náborFáze 3
- Research Site, St Louis
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
Probíhá nábor
- WashU Medicine, St Louis
A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)
Probíhá náborFáze 2
- Local Institution - 109, St Louis
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
Probíhá náborFáze 2/3
- Washington University-Pediatric Cardiology/ St. Louis Children's Hospital ( Site 0006), St Louis
AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
Probíhá náborFáze 2
- Washington University Center for Advanced Medicine, St Louis
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Probíhá náborObservační studie
- St Louis, St Louis
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
Probíhá náborObservační studie
- Washington University, St Louis
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
Probíhá náborFáze 3
- Tenax Investigational Site, St Louis
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Probíhá náborFáze 3
- Washington University, St Louis
- Amicis Centers of Clinical Research, St Louis
Alleviant ALLAY-HF Study
Probíhá nábor
- Washington University - St Louis, St Louis
Assessment of CCM in HF With Higher Ejection Fraction
Probíhá nábor
- St. Louis Heart and Vascular, Bridgeton · Vzdálenost 15 mi
Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia
Probíhá náborFáze 3
- Washington Univ School Of Medicine, St Louis
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
Probíhá náborFáze 3
- Washington University - St. Louis Children's Hospital - Cardiology, St Louis
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
Probíhá náborFáze 3
- Washington University - St. Louis Children's Hospital - Cardiology, St Louis
The Inorganic Nitrate and eXercise Performance in Heart Failure (iNIX-HF)
Probíhá náborFáze 2
- Washington University School of Medicine, St Louis
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
Probíhá nábor
- St. Louis Heart and Vascular, St Louis
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
Probíhá náborFáze 3
- Washington University, St Louis
XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)
Probíhá nábor
- Washington University - Barnes Jewish Health Hospital, St Louis
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
Probíhá náborFáze 1/2
- Washington University in Saint Louis, St Louis
Studie Srdeční selhání v jiných městech
- New York City, NY51 studií
- Boston, MA44 studií
- Dallas, TX42 studií
- Houston, TX36 studií
- Cleveland, OH33 studií
- Chicago, IL31 studií
- Philadelphia, PA31 studií
- San Francisco, CA29 studií
- Durham, NC26 studií
- Kansas City, MO25 studií
- Atlanta, GA25 studií
- Baltimore, MD24 studií
Další studie v St. Louis
- Nemalobuněčný plicní karcinom73 studií
- Rakovina prsu64 studií
- Metastatický karcinom54 studií
- Kolorektální karcinom50 studií
- Rakovina prostaty46 studií
- Rakovina (všechny typy)46 studií
- Rakovina plic39 studií
- Rakovina vaječníků38 studií
- Rakovina slinivky břišní33 studií
- Rakovina endometria29 studií
- Squamózní buněčný karcinom hlavy a krku28 studií
- Obesity25 studií
Zdroj: ClinicalTrials.gov, data načtena 5. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.